Index of reports
> Cases with Rhabdomyolysis (4)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ultracet (Tramadol / Acetaminophen) where reactions include rhabdomyolysis. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Ultracet side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-06-01
Patient: 73 year old female
Reactions: Rhabdomyolysis, Hypercreatininaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-03-08
End date: 2011-12-13
Pantoprazole
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-07-11
End date: 2011-12-13
Fluvastatin
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2011-03-09
End date: 2011-12-13
Ultracet
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-07-01
End date: 2011-12-13
Escitalopram
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-11-07
End date: 2011-12-13
Tramadol HCL
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-12-07
End date: 2011-12-13
Possible Ultracet side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-31
Patient: 73 year old female
Reactions: Rhabdomyolysis, Hypercreatinaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Depakene
Dosage: 400 mg
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-03-08
End date: 2011-12-13
Pantoprazole
Dosage: 40 mg
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-07-11
End date: 2011-12-13
Ultracet
Dosage: 3 df
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-07-01
End date: 2011-12-13
Escitalopram
Dosage: 5 mg
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-11-07
End date: 2011-12-13
Fluvastatin
Dosage: 80 mg
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2011-03-09
End date: 2011-12-13
Tramadol HCL
Dosage: 150 mg
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-12-07
End date: 2011-12-13
Possible Ultracet side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-05-29
Patient: 73 year old female
Reactions: Rhabdomyolysis, Hypercreatininaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Escitalopram
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-11-07
End date: 2011-12-13
Tramadol HCL
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-12-07
End date: 2011-12-13
Depakene
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-03-08
End date: 2011-12-13
Ultracet
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-07-01
End date: 2011-12-13
Pantoprazole
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-07-11
End date: 2011-12-13
Fluvastatin
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2011-03-09
End date: 2011-12-13
Possible Ultracet side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-05-18
Patient: 73 year old female
Reactions: Rhabdomyolysis, Hypercreatininaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Escitalopram
Dosage: 5 mg
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-11-07
End date: 2011-12-13
Ultracet
Dosage: 3 df
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-07-01
End date: 2011-12-13
Pantoprazole
Dosage: 40 mg
Administration route: Oral
Indication: Prophylaxis
Start date: 2011-07-11
End date: 2011-12-13
Tramadol Hydrochloride
Dosage: 150 mg
Administration route: Oral
Indication: Osteoarthritis
Start date: 2011-12-07
End date: 2011-12-13
Depakene
Dosage: 400 mg
Administration route: Oral
Indication: Bipolar Disorder
Start date: 2011-03-08
End date: 2011-12-13
Fluvastatin
Dosage: 80 mg
Administration route: Oral
Indication: Dyslipidaemia
Start date: 2011-03-09
End date: 2011-12-13
|